Thermo Fisher CAO uses 49.899 shares for taxes

THERMO FISHER SCIENTIFIC INC.

Rhea-AI Filing Summary

THERMO FISHER SCIENTIFIC INC. (TMO) reported that officer Joseph R. Holmes, VP & Chief Accounting Officer, had company stock withheld on August 28, 2026 to cover exercise price or tax liability. Four Form 4 transactions show a total of 49.899 shares of common stock disposed at a price of $622.18 per share. These are coded as dispositions for payment of obligations rather than open-market purchases or sales, and post-transaction holdings are not stated in this filing.

Insider Trade Summary

Exercise Price or Tax Liability: 49.899 shares

Exercise Price or Tax Liability 4 txns

Insider Holmes Joseph R.

Role VP & Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	10.567	$622.18	$7K
Exercise Price or Tax Liability	Common Stock	12.915	$622.18	$8K
Exercise Price or Tax Liability	Common Stock	11.447	$622.18	$7K
Exercise Price or Tax Liability	Common Stock	14.97	$622.18	$9K

Holdings After Transaction: Common Stock — 2,916.4565 shares (Direct)

Key Figures

Shares disposed for exercise price or tax liability: 49.899 shares Share price for code F transactions: $622.18 per share Number of code F transactions: 4 transactions +1 more

4 metrics

Shares disposed for exercise price or tax liability 49.899 shares Total code F dispositions by Joseph R. Holmes on August 28, 2026

Share price for code F transactions $622.18 per share Price reported for all four code F transactions on August 28, 2026

Number of code F transactions 4 transactions Non-derivative common stock entries reported for Joseph R. Holmes

Exercise price or tax liability shares 49.899 shares exercisePriceOrTaxLiabilityShares in transaction summary

Key Terms

Form 4, exercise price or tax liability, Rule 10b5-1, Common Stock

4 terms

Form 4 regulatory

"Thermo Fisher Scientific disclosed four separate Form 4 transactions"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

exercise price or tax liability financial

"payment of exercise price or tax liability by delivering or withholding"

Rule 10b5-1 regulatory

"document-level Rule 10b5-1 checkbox is false"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

Common Stock financial

"non-derivative Common Stock entries reported for Joseph R. Holmes"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider transaction did TMO report for Joseph R. Holmes on August 28, 2026?

Thermo Fisher Scientific (TMO) reported that 49.899 shares of common stock tied to VP & Chief Accounting Officer Joseph R. Holmes were disposed of on August 28, 2026 to pay exercise price or tax liability, coded as Form 4 transaction type F.

At what price were the Thermo Fisher (TMO) shares used for Holmes’s tax or exercise obligations?

The Form 4 reports that the shares related to Joseph R. Holmes were valued at $622.18 per share for these transactions on August 28, 2026, consistent across all four code F entries.

How many separate Form 4 transactions did TMO disclose for Joseph R. Holmes?

Thermo Fisher Scientific disclosed four separate Form 4 transactions for Joseph R. Holmes on August 28, 2026, each coded F for payment of exercise price or tax liability by delivering or withholding securities.

Did Joseph R. Holmes of TMO conduct any open-market buys or sells in this Form 4?

No. All reported entries for Joseph R. Holmes are code F, described as payment of exercise price or tax liability by delivering or withholding securities, with no open-market purchases or sales reported in this filing.

Was a Rule 10b5-1 trading plan indicated for the TMO Form 4 transactions?

The filing’s Rule 10b5-1 checkbox is false, indicating these August 28, 2026 transactions were not affirmed as made under a Rule 10b5-1 trading plan in the document-level representation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:12 PM Accepted by SEC EDGAR 09/01/2026 - 04:10 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holmes Joseph R.

(Last) (First) (Middle)

168 THIRD AVENUE

(Street)

WALTHAM MASSACHUSETTS 02451

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
THERMO FISHER SCIENTIFIC INC. [ TMO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP & Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/28/2026		F		10.567	D	$622.18	2,955.7885	D
Common Stock	08/28/2026		F		12.915	D	$622.18	2,942.8735	D
Common Stock	08/28/2026		F		11.447	D	$622.18	2,931.4265	D
Common Stock	08/28/2026		F		14.97	D	$622.18	2,916.4565	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Melodie T. Morin, Attorney-in-Fact for Joseph R. Holmes	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)